Advances in Nasopharyngeal Carcinoma Treatment: Induction Chemotherapy and Concomitant Radio-Chemotherapy

被引：0

作者：

Carvajal, Felipe ^{[1
,2
]}

Luyo, Gustavo ^{[3
]}

Veloso, Javier ^{[6
]}

Veloso, Marcelo ^{[4
]}

Alarcon, Freddy ^{[1
]}

Villa, Eduardo ^{[7
]}

Saavedra, Erika ^{[5
]}

机构：

[1] Inst Nacl Canc, Serv Radioterapia Oncol, Santiago, Chile

[2] Univ Chile, Dept Oncol Basico Clin, Fac Med, Santiago, Chile

[3] Oncosalud AUN, Dept Radioterapia Oncol, Lima, Peru

[4] Inst Nacl Canc, Serv Cirugia Cabeza & Cuello, Santiago, Chile

[5] Inst Nacl Canc, Serv Oncol Med, Santiago, Chile

[6] Univ Los Andes, Med, Santiago, Chile

[7] Univ Chile, Fac Med, Med, Santiago, Chile

来源：

REVISTA MEDICA DE CHILE | 2023年 / 151卷 / 09期

关键词：

Chemoradiotherapy; Drug Therapy; Nasopharyngeal Carcinoma; Radiotherapy; INTENSITY-MODULATED RADIOTHERAPY; LOCALLY ADVANCED HEAD; CONVENTIONAL 2-DIMENSIONAL RADIOTHERAPY; COMPARING NEOADJUVANT CHEMOTHERAPY; PLUS ADJUVANT CHEMOTHERAPY; QUALITY-OF-LIFE; PHASE-III TRIAL; RANDOMIZED-TRIAL; CONCURRENT CHEMORADIOTHERAPY; TREATMENT OUTCOMES;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Squamous cell carcinoma of the nasopharynx is responsible for 0.7% of all malignant tumors worldwide, with the highest incidence in the population of southern China and Southeast Asia. The standard treatment for locally advanced disease consists of a combination of radiotherapy and chemotherapy in different schedules. Among them, induction chemotherapy followed by concomitant radio-chemotherapy has shown in recent years to be a standard therapeutic option with high rates of locoregional control and overall survival. This paper aims to review the current evidence related to treatment with induction chemotherapy and subsequent radio-chemotherapy in nasopharyngeal cancer, its effectiveness, and the technical aspects of its applicability.

引用

页码：1221 / 1232

页数：12

共 56 条

[1] Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099 [J].

Al-Sarraf, M ;

LeBlanc, M ;

Giri, PGS ;

Fu, KK ;

Cooper, J ;

Vuong, T ;

Forastiere, AA ;

Adams, G ;

Sakr, WA ;

Schuller, DE ;

Ensley, JF .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) :1310-1317

[2]

Aw L, 2019, Int J Radiat Oncol Biol Phys Internet, V105

[3] Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer Group [J].

Blanchard, Pierre ;

Bourhis, Jean ;

Lacas, Benjamin ;

Posner, Marshall R. ;

Vermorken, Jan B. ;

Cruz Hernandez, Juan J. ;

Bourredjem, Abderrahmane ;

Calais, Gilles ;

Paccagnella, Adriano ;

Hitt, Ricardo ;

Pignon, Jean-Pierre .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (23) :2854-+

[4] Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].

Bossi, P. ;

Chan, A. T. ;

Licitra, L. ;

Trama, A. ;

Orlandi, E. ;

Hui, E. P. ;

Halamkova, J. ;

Mattheis, S. ;

Baujat, B. ;

Hardillo, J. ;

Smeele, L. ;

van Herpen, C. ;

Castro, A. ;

Machiels, J-P .

ANNALS OF ONCOLOGY, 2021, 32 (04) :452-465

[5] Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Progression-free survival analysis of a phase III randomized trial [J].

Chan, ATC ;

Teo, PML ;

Ngan, RK ;

Leung, TW ;

Lau, WH ;

Zee, B ;

Leung, SF ;

Cheung, FY ;

Yeo, W ;

Yiu, HH ;

Yu, KH ;

Chiu, KW ;

Chan, DT ;

Mok, T ;

Yuen, KT ;

Mo, F ;

Lai, M ;

Kwan, WH ;

Choi, P ;

Johnson, PJ .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (08) :2038-2044

[6] Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial [J].

Chen, Lei ;

Hu, Chao-Su ;

Chen, Xiao-Zhong ;

Hu, Guo-Qing ;

Cheng, Zhi-Bin ;

Sun, Yan ;

Li, Wei-Xiong ;

Chen, Yuan-Yuan ;

Xie, Fang-Yun ;

Liang, Shao-Bo ;

Chen, Yong ;

Xu, Ting-Ting ;

Li, Bin ;

Long, Guo-Xian ;

Wang, Si-Yang ;

Zheng, Bao-Min ;

Guo, Ying ;

Sun, Ying ;

Mao, Yan-Ping ;

Tang, Ling-Long ;

Chen, Yu-Ming ;

Liu, Meng-Zhong ;

Ma, Jun .

LANCET ONCOLOGY, 2012, 13 (02) :163-171

[7] Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline [J].

Chen, Yu-Pei ;

Ismaila, Nofisat ;

Chua, Melvin L. K. ;

Colevas, A. Dimitrios ;

Haddad, Robert ;

Huang, Shao Hui ;

Wee, Joseph T. S. ;

Whitley, Alexander C. ;

Yi, Jun-Lin ;

Yom, Sue S. ;

Chan, Anthony T. C. ;

Hu, Chao-Su ;

Lang, Jin-Yi ;

Le, Quynh-Thu ;

Lee, Anne W. M. ;

Lee, Nancy ;

Lin, Jin-Ching ;

Ma, Brigette ;

Morgan, Thomas J. ;

Shah, Jatin ;

Sun, Ying ;

Ma, Jun .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (07) :840-+

[8] Nasopharyngeal carcinoma [J].

Chen, Yu-Pei ;

Chan, Anthony T. C. ;

Quynh-Thu Le ;

Blanchard, Pierre ;

Sun, Ying ;

Ma, Jun .

LANCET, 2019, 394 (10192) :64-80

[9]

Chua DTT, 1998, CANCER, V83, P2270, DOI 10.1002/(SICI)1097-0142(19981201)83:11<2270::AID-CNCR6>3.3.CO

[10]

2-K

← 1 2 3 4 5 6 →